These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484 [TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. Shegogue D; Trojanowska M J Biol Chem; 2004 May; 279(22):23166-75. PubMed ID: 15047702 [TBL] [Abstract][Full Text] [Related]
25. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Langenfeld EM; Kong Y; Langenfeld J Mol Cancer Res; 2005 Dec; 3(12):679-84. PubMed ID: 16380505 [TBL] [Abstract][Full Text] [Related]
28. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. Kawauchi K; Ihjima K; Yamada O J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522 [TBL] [Abstract][Full Text] [Related]
29. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463 [TBL] [Abstract][Full Text] [Related]
30. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. Rodríguez A; Catalán V; Gómez-Ambrosi J; García-Navarro S; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Burrell MA; Calamita G; Malagón MM; Frühbeck G J Clin Endocrinol Metab; 2011 Apr; 96(4):E586-97. PubMed ID: 21289260 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. Kristof AS; Marks-Konczalik J; Billings E; Moss J J Biol Chem; 2003 Sep; 278(36):33637-44. PubMed ID: 12807916 [TBL] [Abstract][Full Text] [Related]
32. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571 [TBL] [Abstract][Full Text] [Related]
33. Akt2, but not Akt1 or Akt3 mediates pressure-stimulated serum-opsonized latex bead phagocytosis through activating mTOR and p70 S6 kinase. Shiratsuchi H; Basson MD J Cell Biochem; 2007 Oct; 102(2):353-67. PubMed ID: 17372934 [TBL] [Abstract][Full Text] [Related]
34. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Liu Y; Fanburg BL Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541 [TBL] [Abstract][Full Text] [Related]
35. Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors. Lu C; Willingham MC; Furuya F; Cheng SY Endocrinology; 2008 Jul; 149(7):3339-45. PubMed ID: 18356276 [TBL] [Abstract][Full Text] [Related]
36. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340 [TBL] [Abstract][Full Text] [Related]
37. Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib. Duan Z; Li J; Pang X; Wang H; Su Z Cell Physiol Biochem; 2018; 48(1):54-62. PubMed ID: 29996117 [TBL] [Abstract][Full Text] [Related]
38. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related]
39. Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation. Winbanks CE; Grimwood L; Gasser A; Darby IA; Hewitson TD; Becker GJ Int J Biochem Cell Biol; 2007; 39(1):206-19. PubMed ID: 16973406 [TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]